S095035

PreclinicalSmall molecule

SServier Bio-Innovation LLC

S095035 is one of 3 small molecule programs targeting MTAP-deleted Solid Tumors. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MTAP-Deleted Solid TumorsActive, not recruiting

MTAP-Deleted Solid TumorsPreclinical

Active, not recruiting

Competition

Competitive Landscape

4 competitors in MTAP-Deleted Solid Tumors

#DrugCompanyPhaseTrials

BAY 987519

Bayer

Preclinical

1 2

TNG462

TTango Therapeutics, Inc.

Preclinical

1 3

S095035

SServier Bio-Innovation LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

PreclinicalActive, not recruiting

MTAP-Deleted Solid Tumors

NCT06188702

Clinical

Trials by Indication[1]

MTAP-deleted Solid Tumors1 trial

A Phase 1/2, Open-label, Multicenter Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Antineoplastic Activity of S095035 (MAT2A Inhibitor) as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Homozygous Deletion of MTAP

Active, not recruiting·SServier Bio-Innovation LLC·Preclinical·NCT06188702·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for S095035. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — S095035 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for S095035. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Servier Bio-Innovation LLC company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SServier Bio-Innovation LLC

S095035

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

MTAP-deleted Solid Tumors1 trial

References

Drug Info

Quick Facts

Related News